Brief: Hyphens Pharma International Updates On Cerapro® Med Skin Barrier Cream
05/01/2026 10:26
Jan 5 (Reuters) - Hyphens Pharma International Ltd HYPH.SI: GRANTED RIGHTS TO COMMERCIALISE ITS CERAPRO® MED SKIN BARRIER CREAM, TO LOUIS WIDMER SA IN ACCORDANCE WITH AGREEMENT CO WILL RECEIVE UPFRONT FEE ,CUSTOMARY ROYALTIES ON SALES Further company coverage: HYPH.SI ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyphens Pharma International
See all newsBrief: Hyphens Pharma International Updates On Cerapro® Med Skin Barrier Cream
Brief: Hyphens Pharma International Says Unit Gets Exclusive Rights To Commercialise Metoject
Brief: Hyphens Pharma International Posts FY Net Income Of SGD 10.9 Million
Brief: Hyphens Pharma International Licenses Amenalief From Maruho For ASEAN
Brief: Hyphens Pharma International Posts Net Profit After Tax In 1Q2024 S$2.7 Million